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The formation of neuronal circuits during development involves a combination of synapse stabilization and elimination events. Synaptic
adhesionmolecules are thought to play an important role in synaptogenesis, and several trans-synaptic adhesion systems that promote
the formation andmaturation of synapses have been identified. The neuroligin–neurexin complex is a heterophilic adhesion system that
promotes assembly and maturation of synapses through bidirectional signaling. In this protein complex, postsynaptic neuroligins are
thought to interact trans-synaptically with presynaptic neurexins. However, the subcellular localization of neurexins has not been
determined. Using immunoelectron microscopy, we found that endogenous neurexins and epitope-tagged neurexin-1 are localized to
axons and presynaptic terminals in vivo. Unexpectedly, neurexins are also abundant in the postsynaptic density. cis-expression of
neurexin-1 with neuroligin-1 inhibits trans-binding to recombinant neurexins, blocks the synaptogenic activity of neuroligin-1, and
reduces the density of presynaptic terminals in cultured hippocampal neurons. Our results demonstrate that the function of neurexin
proteins ismore diverse than previously anticipated and suggest that postsynaptic cis-interactionsmight provide a novelmechanism for
silencing the activity of a synaptic adhesion complex.
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Introduction
Central synapses are specialized cell–cell junctions that relay in-
formation between neurons. The highly organized presynaptic
and postsynaptic domains are linked through trans-synaptic ad-
hesion complexes (Fannon and Colman, 1996; Yamagata et al.,
2003). Although adhesive interactions provide synaptic junctions
with a remarkablemechanical stability, synapses nevertheless can
dynamically change their size and can be rapidly eliminated
(Goda andDavis, 2003). This implies thatmechanismsmust exist
that weaken synaptic adhesion complexes and lead to their
disassembly.
Recent studies identified several adhesion molecules that
might contribute to the assembly and stability of synapses, in-
cluding the neuroligin–neurexin complex (Benson et al., 2001;
Scheiffele, 2003;Waites et al., 2005). Neuroligins (NL1–NL4) are
postsynaptic proteins containing an extracellular cholinesterase
domain (Song et al., 1999). Neurexins (NRX1–NRX3) are pre-
sumptive axonal receptors that bind to neuroligins through an
extracellular LNS (laminin–neurexin–sex-hormone-binding
protein) domain. Each neurexin gene gives rise to  and  iso-
forms that exhibit differential interaction with neuroligins, and
interactions are further regulated through alternative splicing
(Ichtchenko et al., 1995; Boucard et al., 2005; Chih et al., 2006;
Graf et al., 2006).
Functional in vitro assays revealed that the neuroligin–neur-
exin complex has potent synaptogenic activities: NL1 expressed
in non-neuronal cells or overexpression in cultured neurons trig-
gers the assembly of presynaptic elements (Scheiffele et al., 2000;
Dean et al., 2003), whereas disruption of neuroligin function
perturbs synaptic differentiation (Scheiffele et al., 2000; Graf et
al., 2004; Prange et al., 2004; Chih et al., 2005; Levinson et al.,
2005; Nam and Chen, 2005). Mice lacking all three major neu-
roligin isoforms die at birth. Although anatomical studies of neu-
roligin triple knock-out mice reveal only moderate changes on
the structural level, there are severe defects in synaptic transmis-
sion (Varoqueaux et al., 2006). This suggests that loss of some of
the structural synapse assembly activities of neuroligins can be
compensated but that neuroligins are essential for the formation
of functional synaptic connections.
All current models of the neuroligin–neurexin complex rely
on the presynaptic localization of neurexins, but several findings
have challenged this view. In electric ray, neurexins were sug-
gested to be present in axons but absent from synapses (Russell
and Carlson, 1997). Cortical neurons lacking all -neurexins
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show defects in postsynaptic glutamate receptor function (Kat-
tenstroth et al., 2004), and neurexins are enriched in postsynaptic
density (PSD) preparations (Peng et al., 2004). Resolving these
discrepancies requires ultrastructural studies of neurexin local-
ization, which have not been performed. If neurexins were local-
ized to the postsynaptic compartment, then a puzzling question is
whether coexistence of the neurexin–neuroligin pair within the
same membrane leads to cis-interactions.
We examined the subcellular localization of neurexins in vivo.
Our results confirm the presynaptic localization of neurexins but
also reveal an unexpected accumulation in the postsynaptic den-
sity. We probed the consequences of neurexin and neuroligin
coexpression and found that cis-expressed-neurexins inactivate
NL1 and promote the destabilization of synapses. These findings
reveal a candidate mechanism for the regulation of neuroligin
activity and demonstrate that neurexin functions are more com-
plex than previously anticipated.
Materials andMethods
DNA constructs. For expression experiments, cDNAs were inserted into
the pCAGGS vector under control of the chicken -actin promoter.
Studies were performed with the NL1 splice isoform containing A and B
insertions with a vesicular stomatitis virus (VSV) epitope tag inserted
after the signal sequence. Transfected neurexin isoforms contained an
hemagglutinin (HA) tag inserted after the signal peptide. An
NRX14() cDNA was isolated by reverse transcription-PCR from an
embryonic day 18 rat whole-brain cDNA preparation. In the NRXLNS
mutant, amino acids 109–233 of NRX1, corresponding to the  sheets
3–12 within the LNS domain, were deleted. The construct encoding the
neurexin–Fc fusion protein has been described previously (Scheiffele et
al., 2000).
Generation of green fluorescent protein–neurexin mice. Green fluores-
cent protein (GFP)–NRX14() containing a VSV epitope after the
signal sequence (alanine 47) and the cDNA encoding enhanced GFP
(EGFP) in the extracellular stalk region (Threonine 302) was introduced
into a Thy1.2 expression cassette (Caroni, 1997). After linearization, the
construct was introduced into fertilized eggs derived from B6CBAF1
mice by pronuclear injection. Pseudopregnant CD-1 outbred albino fe-
males were used as foster mothers for embryo transfer. Founder and
transgenic mice were genotyped by PCR of tail genomic DNA, using
primers derived from NRX1 cDNA and EGFP coding sequences.
Founders were further crossed with B6CBAF1mice to generate lines and
backcrossed to C57BL/6. Quantitative PCR for measuring neurexin
overexpression level were performed using a Light CyclerMX3000Pwith
Brilliant SYBRGreen (Stratagene, La Jolla, CA).NRX1primerswere used
to amplify a product containing sequences of exons 19 and 20, and prim-
ers for -actin were used as a normalization control.
Antibodies. Pan-neuroligin antibodies were raised against a recombi-
nant protein containing the cytoplasmic tail of NL1 fused to glutathione
S-transferase. Rabbit sera were affinity purified over a recombinant pro-
tein containing the same cytoplasmic tail fused to maltose-binding pro-
tein. Affinity-purified antibodies recognized NL1–NL4 isoforms with
comparable affinity inWestern blots (supplemental Fig. S3B, available at
www.jneurosci.org as supplementalmaterial). Anti-GFP antibodies were
generated in rabbits and affinity purified using recombinant EGFP pro-
duced in Escherichia coli. Chicken anti-pan-neurexin antibodies have
been described previously (Dean et al., 2003). Commercially available
primary antibodies used in this study were as follows: mouse anti-
calbindin (Swant, Bellizona, Switzerland), chicken anti-GFP (Upstate
Biotechnology, Lake Placid, NY), rabbit anti-vesicular glutamate trans-
porter (vGlut1) (Synaptic Systems, Goettingen, Germany), mouse
anti-PSD95 (Affinity BioReagents, Golden, CO), mouse anti-vesicle-
associatedmembrane protein (VAMP2) (Synaptic Systems),mouse anti-
early endosomal antigen 1 (EEA1) (BD Transduction Laboratories, Lex-
ington, KY), rabbit anti-VSV (Stressgen, Victoria, British Columbia,
Canada), and rat anti-HA (Roche, Indianapolis, IN). Highly cross-
absorbed secondary antibodies raised in donkey and conjugated to cya-
nine 2 (Cy2), Cy3, and Cy5 were used for multiple labeling experiments
(Jackson ImmunoResearch,West Grove, PA). Antibodies for EMwere as
follows: biotinylated goat anti-rabbit IgGs and biotinylated goat anti-
chicken IgGs (Vector Laboratories, Burlingame, CA), 0.8 nm gold-
conjugated goat anti-biotin IgG and 10 nm gold-conjugated goat anti-
chicken IgG (Electron Microscoscopy Sciences/Aurion, Fort
Washington, PA), and rabbit anti-GFP (Invitrogen, Carlsbad, CA).
Cell culture and transfection. For dissociated hippocampal cultures,
tissue was dissected from embryonic day 18–19 rat brains, treated with
0.25% trypsin in DMEM with high glucose (Invitrogen) for 25 min at
37°C, and was triturated by pipetting. Dissociated cells were plated on
poly-D-lysine-coated glass coverslips at a density of 25,000/cm2 and
maintained in neurobasal medium (Invitrogen) supplemented with 2
mMGlutamax (Invitrogen), B27 (Invitrogen), and penicillin/streptomy-
cin (Invitrogen) at 37°C and 5% CO2. Cells were transfected using Lipo-
fectamine 2000 (Invitrogen) at 12–15 d in vitro (DIV) after plating and
fixed 2–3 d after transfection (Dean and Scheiffele, 2004).
Human embryonic kidney (HEK293) cells weremaintained inDMEM
containing 10% fetal bovine serum and penicillin/streptomycin. Cells
were transfected using Lipofectamine Plus (Invitrogen). For the mixed
culture assaywithHEK293 cells and hippocampal neurons,HEK293 cells
were transfected for 3 h followed by dissociation with trypsin. The cell
suspension was washed and resuspended in neurobasal medium, and
cells were added into 10 DIV neuronal cultures at a density of 8,000/cm2
and maintained for 2 d.
Light microscopy.Cultured cells were fixed with 4% paraformaldehyde
(PFA) in phosphate buffer (PB) containing 4% sucrose and were perme-
abilized and blocked with 10% normal goat serum in PBS containing
0.1% Triton X-100. For immunostaining with anti-PSD95 antibodies,
cells were first fixed with 4% PFA for 5 min, followed by methanol
fixation. Cells were incubated with primary and secondary antibodies for
2–24 h in the sameblocking solution. Cell surface stainingwas performed
by incubating cells with primary antibodies without permeabilization.
For analysis of GFP–NRX14() mice, animals were perfused with
4% paraformaldehyde in PBS. Brains were isolated and incubated in the
same fixative overnight. Then tissues were cut into 30 m sections using
vibratome (Leica, Nussloch, Germany). Sections were blocked and per-
meabilized in 5% BSA and 0.5% Triton X-100 in PBS for 1 h at room
temperature. Antibodies were diluted in 5% BSA and 0.05% Triton
X-100 in PBS. Primary antibody incubationwas 3 h at room temperature
or overnight at 4°C. Secondary antibody incubation was for 1 h at room
temperature. Sections were mounted and analyzed by fluorescence
microscopy.
Preparation of tissue for electron microscopic immunocytochemistry. A
pan-NRX antibody directed against the conserved cytoplasmic tail of
neurexins (Dean et al., 2003) was used to localize neurexins within intact
tissue of rat brains. Three adult and three postnatal day 7 (P7)Wistar rats
were transcardially perfused with a mixture of aldehydes to fix the brain.
All fixatives contained 0.1 M PB, pH 7.4, and 4% paraformaldehyde. This
was supplemented with 1% glutaraldehyde or 3% acrolein or neither.
Slabs of brains were sectioned in the sagittal or coronal plane, using a
vibratome, and fixation was terminated by reacting free-floating sections
with 1% sodium borohydride made in 0.1 M PB. Sections were stored at
5°C, free floating in a solution consisting of 0.9% sodium chloride (sa-
line), 0.01 M phosphate buffer, pH 7.4, and 0.05% sodium azide (PBS-
azide) to prevent bacterial growth. Antigenic sites were localized using
one of two different electron-dense immunolabels: horseradish peroxi-
dase–diaminobenzidine (HRP–DAB) reaction product for pre-embed
immunolabeling and 10 nm colloidal gold particles for post-embed im-
munogold (PEG) labeling. HRP–DAB reaction product was used to
maximize detection of neurexin. PEG was used to optimize detection of
the antigen at the synaptic junction. For the pre-embed immunolabeling
procedure, tissue was first permeabilized by repeated freeze–thawing and
then treatedwith 1%hydrogen peroxide in PBS for antigen retrieval. The
chicken anti-pan-NRX (Dean et al., 2003) was applied by gentle tum-
bling of free-floating vibratome sections in PBS-azide containing the
antibody at a dilution of 1:75 or 1:120 and 1% bovine serum albumin to
minimize background labeling. The incubation period was for 3 d at
room temperature. Additional fixation of vibratome sections with 1%
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osmium tetroxide was performed at the end of the immunocytochemical
procedure. For control, free-floating sections were incubated identically,
except that the 3 d incubation was performed using a pan-NRX primary
antibody that had been preadsorbed by the neurexin-1–maltose binding
protein fusion protein used to affinity purify the antibody. This control
condition yielded no labeling over synapses (see Fig. 1B) (supplemental
Fig. S1A,B, available at www.jneurosci.org as supplemental material).
For PEG, the pan-NRX primary antibody was applied to ultrathin
sections mounted on Formvar-coated grids at a dilution of 1:25 over-
night at room temperature. These ultrathin sections were collected from
vibratome sections of brains that were fixed by transcardial perfusion
with 4% paraformaldehyde and 1% glutaraldehyde, followed by 1% os-
mium tetroxide fixation of vibratome sections. For PEG controls, grids
were incubated overnight in the same buffer but with the primary anti-
body omitted. Similar results were obtained with pan-NRX antibodies
isolated from two different animals that had been immunized with the
neurexin antigen, whereas controls showed complete elimination of la-
beling over synapses and axons.
Anti-GFP antibodies for detection of GFP–NRX in transgenic mice
were used at a dilution ranging from 1:2000 up to 1:6000. Two pre-
embed immunolabeling procedures were used: HRP–DAB reaction
product to maximize detection of GFP–NRX and silver-intensified gold
(SIG) to distinguish and quantify the membranous versus intracellular
sites of the antigen. For both procedures, the immunolabeling of wild-
type littermates of the transgenic mice served as controls (supplemental
Fig. S1C, available at www.jneurosci.org as supplemental material). Vi-
bratome sections of transgenic and wild-type mice were collected from
brains fixed by transcardial perfusion with 4% paraformaldehyde. The
HRP–DAB-labeled vibratome sections were further fixed with 1% os-
mium tetroxide, whereas the SIG-labeled vibratome sections were fixed
using Phend’s osmium-free tissue fixation method.
Additional details of steps for generating the three electron-dense la-
bels (SIG, HRP–DAB, and PEG) were as described previously (Phend et
al., 1995; Aoki et al., 2001, 2005).
Image acquisition and quantification.All quantitationswere performed
for at least three independent experiments. In each single experiment, at
least 10 cells were quantitatively analyzed per condition. Images for each
experiment were acquired using a Zeiss (Oberkochen, Germany)
LSM510 confocal microscope using the same settings for laser power,
gain, and offset for all images. Projections of Z-stacked images were
analyzed by MetaMorph software (Molecular Devices, Palo Alto, CA).
For neuroligin–neurexin coexpression studies, neuroligin-positive areas
were selected by thresholding using the same threshold for all images.
The threshold was set such that most of the specific neuroligin signal was
selected, even in cells with low expression level. The outlines of
neuroligin-positive regions were transferred into the VAMP2 channel,
and the average staining intensity of VAMP2 was calculated. For experi-
ments in which different neurexin constructs and EGFP were expressed
in neurons, the GFP-expressing regions of 50 m dendritic segments
were selected by thresholding. The outlines of GFP regions were im-
ported into the vGlut1 channel. The outlines of the GFP signal were
modified such that also vGlut1 puncta only partially overlappingwith the
GFP area were fully included into the analysis. Using these modified
regions, the total area of vGlut1 with staining intensity above threshold
was measured.
For NRX14()–Fc binding assays, regions representing theHEK293
cells and/or 50mdendritic segments were determined by thresholding.
Then the average NRX14()–Fc staining intensity and total area with
staining intensity above a threshold was calculated. For experiments in
which neurons expressing different neurexin constructs were stained
with pan-NL antibodies, the neurexin-positive regions in 50 m den-
dritic segments were determined by thresholding, and within these re-
gions average staining intensity for pan-neuroligin was calculated. Sta-
tistical analysis was performed using ANOVA followed by Dunnett’s
multiple comparison test.
EM images were acquired digitally, using the AMT (Perth, West Aus-
tralia, Australia) software andHamamatsu (Bridgewater, NJ) CCD cam-
era or using EM negatives. For pre-embed immunolabeled materials,
antigenic sites were categorized as residing over the plasma membrane
versus intracellular portions of axons of dendrites or somata and presyn-
aptically or postsynaptically. For post-embed immunolabeled materials,
the antigenic sites labeled with PEG particles were quantified as follows.
All PEG particles at labeled synapses (identified by PEG labeling within
50 nm from the postsynaptic membrane) were counted and grouped
into bins according their distance from the postsynaptic membrane. Fig-
ure 1F shows the number of gold particles within 0–10, 10–20, 20–30
nm, etc., from the postsynaptic membrane. Student’s t test was per-
formed to determine whether the total and subcellular distribution of
SIG or PEG particles reflecting antigenic sites differed significantly from
control conditions. All statistical analyses revealed highly significant dif-
ferences ( p 0.001).
Soluble neurexin binding assay. Soluble neurexin was produced in
HEK293 cells transfected with pCAGGS driving expression of an
NRX14()–Fc fusion protein as described previously (Scheiffele et al.,
2000). For the neuronal binding assays, purified soluble neurexin was
used at a concentration of 5 g/ml in neurobasal medium.
HEK293 cells or hippocampal neurons were washed inmedium (5mM
CaCl2 in DMEMor neurobasal, respectively) and incubated with soluble
neurexin for 20 min at 20°C. After washing with medium, the cells were
fixed with 4% PFA, and bound protein was detected by immunohisto-
chemistry in nonpermeabilized cells.
Results
Neurexins are localized presynaptically and postsynaptically
in vivo
To directly investigate the distribution of endogenous neurexins
by immunoelectron microscopy, we used a pan-neurexin anti-
body directed against the conserved cytoplasmic tail of neurexins,
which cross-reacts with the majority of - and -neurexin iso-
forms (Dean et al., 2003). Immunoelectron microscopy with
these antibodies performed with HRP–DAB detection on post-
natal day 7 rat cerebellum, cortex, and hippocampus revealed
strong neurexin immunoreactivity in the endoplasmic reticulum
of neurons, on axonal growth cones, preterminal portions of
axons, and synaptic structures (Fig. 1A and data not shown).
Similar labeling was observed with the affinity-purified antibody
preparations obtained from two different immunized animals,
and labeling was lost when primary antibodies were omitted or
were cross-absorbed with the antigen before incubation with the
tissue (Fig. 1B) (supplemental Fig. S1. available at www.jneuro-
sci.org as supplemental material).
To optimize immunolabeling of antigens at the synaptic junc-
tion, PEG labeling was performed. At synapses of P7 and P8
cerebral cortex, gold particles decorated the presynaptic active
zones (Fig. 1C) and vesicular structures in the preterminal por-
tions of axons. Surprisingly, we also observed prominent labeling
of postsynaptic structures. Gold particles were observed clustered
directly at the postsynaptic membrane, over the postsynaptic
density, and inside the postsynaptic spine, including the intracel-
lularmembranes of the spine apparatus (Fig. 1D,E).Quantitative
analysis of gold particles at synapses revealed a peak centered
within 10 nm of the postsynaptic membrane and confirmed sim-
ilar labeling efficiency of both presynaptic and postsynaptic sites
(Fig. 1F) (419 PEG particles, 111 synapses, 4 grids, all PEG par-
ticles counted). This distribution highlights that the postsynaptic
pool of neurexins is of a significant size and that the level of
neurexin immunoreactivity is similar in the presynaptic and
postsynaptic compartments.Whenwe scored synapses according
to the presence of PEG labeling exclusively in the presynaptic or
postsynaptic side or labeling in both synaptic compartments, we
observed that 35% showed labeling on both sides, whereas 26%
were labeled exclusively presynaptically and 39% were labeled
exclusively on the postsynaptic side (total of 163 synapses from
two independent experiments). In this analysis, only structures
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labeledwith aminimumof three PEGpar-
ticles were considered positive. However,
the conclusions did not change even when
all PEG-positive structures were scored
(total of 205 labeled synapses, 27% pre-
synaptic only, 34% postsynaptic only,
39% both sides labeled). These findings
show that endogenous neurexin proteins
are concentrated at synapses in vivo and
that a major pool of endogenous neurex-
ins localizes to the postsynaptic
compartment.
The pan-neurexin antibodies do not
allow any conclusions regarding the spe-
cific neurexin isoforms that are targeted to
presynaptic and/or postsynaptic sites. To
specifically investigate the subcellular tar-
geting of NRX14() (a neurexin-1
splice isoform containing an insertion in
site 4), we generated transgenic mice ex-
pressing a GFP-tagged form of the protein
under control of the neuron-specific
Thy1.2 promoter (Fig. 2A). In previous
studies, we confirmed that incorporation
of GFP into the juxtamembrane domain
of neurexins does not significantly alter
their intracellular transport and the ability
to interact with neuroligins in vitro (data
not shown).
As demonstrated in previous studies
(Caroni, 1997; Feng et al., 2000), expres-
sion from the Thy1.2 promoter resulted in
labeling of different subsets of neurons in
the different mouse lines (data not
shown). The NRX1 mRNA overexpres-
sion level in the transgenic mice was esti-
mated by quantitative PCR using primers
specific for the 4() variant. Compared
with endogenous NRX1, the mRNA level
was estimated to be increased less than
sevenfold. Considering that NRX1–NRX3
genes are coexpressed in most neurons,
the overexpression compared with the to-
tal neurexin level is significantly lower
than this. In all lines, we observed promi-
nent labeling of axon tracts and synapse-
rich areas (data not shown). One repre-
sentative line was used for a more detailed
anatomical analysis. In the hippocampus,
prominent GFP–NRX14() expression
was observed in the dentate granule cells,
so identified by their immunoreactivity to
calbindin (Fig. 2B). Immunohistochemis-
try with anti-GFP antibodies revealed
prominent labeling of themossy fiber pro-
jection to the CA3 field of the hippocam-
pus as well as the inner molecular layer of the dentate gyrus, sites
in which synapses with commissural axons of the association
path are received (Fig. 2B). Under the same staining conditions,
no significant labeling was observed in wild-type mice (supple-
mental Fig. S1D,E, available at www.jneurosci.org as supplemen-
tal material). In the cortex, GFP–NRX14() labeling was de-
tected in neuronal cell bodies, especially of layer 5 pyramidal
neurons, and along their apical dendrites (Fig. 2C). These find-
ings support a prominent localization of tagged NRX14() in
axon tracts and in synapse-rich areas of the cortex andhippocam-
pus by light microscopy.
We next analyzed GFP–NRX14() localization in layers 5
through 6 of the cortex, the CA3 field of the hippocampus, and
the inner molecular layer of the dentate gyrus by immunoelec-
Figure 1. Ultrastructural localization of neurexins in P7 and P8 cerebral cortices and cerebellum of rats as visualized by the
HRP–DAB and PEG immunolabels. Using a pan-neurexin antibody followed by HRP–DAB and PEG immunolabels, the variety of
perisynaptic positions taken by neurexin is shown. A, HRP–DAB revealed neurexin labeling within many axons of the molecular
layer of P7 cerebellum, one example of which is shown here (l-ax). Immediately adjacent to l-ax is an example of dense immuno-
labeling that occurs along the postsynaptic membrane and intracellularly within spines (l-sp). In contrast, the axon terminal that
is presynaptic to the labeled spine is unlabeled (t). Scale bar, 500 nm (also applies to B). Arrows here and in all other panels point
to the postsynaptic density. Tissue for this analysiswas fixedwith 4%paraformaldehyde. Subsequent to the immunocytochemical
procedure, the vibratome sections were fixed using 1% glutaraldehyde, followed by 1% osmium tetroxide and counterstaining
with 1% uranyl acetate. The lightmicroscopic images of the vibratome section fromwhich these ultrathin sections were sampled
are shown in supplemental Figure S1 (available at www.jneurosci.org as supplemental material). B, Vibratome section of P7
cerebellum taken semi-adjacent incubated using the same pan-neurexin antibody that was preabsorbed with the antigen. Im-
munolabeling was eliminated from spines and axons. C–E, Clusters of immunogold labeling achieved at the PEG stage occur
discretely along the plasma membrane of synapses in the infragranular layers of P7 cerebral cortex. C shows an example of PEG
particles at andnear thepresynapticmembraneof anaxon terminal (t) and in the cleft.D andE showclusters of PEGparticles along
the postsynaptic membrane and PSD of dendritic spines (sp) and the synaptic cleft. E shows additional PEG clustered along the
spine apparatus andpresynaptic terminal (t). Scale bar, 200nm (also applies to C–E). F, The PEGparticle distributionwas analyzed
relative to synaptic junctions. PEG positionsweremeasured as distance, in nanometers, from the postsynapticmembrane, and all
PEG particles were counted in mutually exclusive bins (0–10, 10–20, 20–30 nm, etc.). These distances span six categories
described to the left of the diagramas “Within Terminals,” “At/Near PresynapticMembrane,” “At cleft,” “At PSD,” “Near PSD” (and
along the postsynaptic membrane), and “Within Spines” (but away from the PSD). This analysis was based on 419 PEG particles
that were associated with 111 labeled synapses showing clear presentation of the synaptic cleft. The labeled synapses were
encountered across four grids.
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tron microscopy on P14 animals using anti-GFP antibodies fol-
lowed by SIG labeling (Fig. 2D,E). Staining of tissue from wild-
type animals revealed negligible labeling with anti-GFP
antibodies (supplemental Fig. S1C, available at www.jneurosci.
org as supplemental material), indicating that labeling for GFP–
neurexin obtained in tissue from transgenic animals was highly
specific. As observed with the pan-neurexin antibodies, also the
tagged NRX14() protein was detected in axons (Fig. 2D) and
dendrites (Fig. 2E). At the cell surface, we observed strongest
immunoreactivity at the plasmamembrane of axons (51 4 and
55  6% of particles in cortex and hippocampal formation, re-
spectively), followed by the plasmamembrane of dendrites (11
2 and 17 3%, respectively) (Table 1). At some synapses, prom-
inent labeling was observed in presynaptic or postsynaptic com-
partments, directly at the active zone and postsynaptic density
(Fig. 2E). In general, synaptic labeling was less frequently ob-
served than nonsynaptic labeling. This might in part be attribut-
able to reduced accessibility of the extracellular GFP epitope in
the synaptic cleft compared with the pan-neurexin antibody that
recognizes the cytoplasmic tail of neurexins. Regardless, these
data reveal axonal and dendritic localization of the transgenically
expressed GFP-tagged NRX14() isoform and further suggest
that neurexin proteins are not restricted to axons but can also
found in dendrites and at some postsynaptic sites.
Postsynaptic neurexin expression alters neuroligin activity
Previous work demonstrated that NL1 is selectively targeted to
dendrites in which it is concentrated in the postsynaptic mem-
brane (Song et al., 1999; Dresbach et al., 2004; Iida et al., 2004;
Rosales et al., 2005). Our finding that neurexins are present at
significant levels in dendrites raises the question whether its co-
expression in the samemembranewithNL1might affect neuroli-
gin function. To test this possibility, we examined whether cis-
expressed NRX1 isoforms alter the ability of NL1 to stimulate
presynaptic differentiation. Overexpression of NL1 in cultured
hippocampal neurons leads to an increase in the density of syn-
aptic vesicle clusters formed on the transfected cells (Dean et al.,
2003; Prange et al., 2004; Chih et al., 2005; Sara et al., 2005) (Fig.
3A). Cotransfection of NL1 expression vectors with cDNAs en-
coding NRX14() and NRX14() (isoforms lacking and
containing an insertion in splice site 4) potently suppressedNL1-
induced synaptic vesicle clustering (Fig. 3A,B). In contrast, co-
expression of EphB2, a postsynaptic receptor implicated in glu-
tamatergic synapse formation (Dalva et al., 2000), did not alter
NL1 activity in this assay (Fig. 3B). Some suppression activity was
also observed for theNRX14() isoform, although this isoform
wasmuch less potent than the-neurexins tested. Deletion of the
extracellular LNS domain in NRX1, which represents the neu-
roligin binding site, resulted in a complete loss of the suppression
activity (NRXLNS) (Fig. 3A,B). Importantly, the loss of synap-
tic vesicle clustering was not attributable to reduced surface levels
of the expressed NL1 protein on the transfected cells because
quantitative analysis in nonpermeabilized cells confirmed com-
parableNL1protein levels formost conditions.Weonly observed
a slight reduction in NL1 expression in the cotransfection with
NRX14() and EphB2 (Fig. 3C). However, NL1 levels were
identical to control in the cells expressingNRX14() and 4(),
the two isoforms with the most potent silencing activity. In sum-
mary, these findings reveal an unexpected new activity of
-neurexins in cultured hippocampal neurons.
Direct regulation of neuroligin activity by neurexin in cis
Postsynaptic -neurexins might affect NL1 activity by either di-
rectly altering the function of NL1 or affecting other postsynaptic
factors in hippocampal neurons. To test whether neurexins can
directly alter neuroligin activity, we used amixed culture assay in
which NL1 expressed in non-neuronal cells is used to induce the
assembly of presynaptic structures in axons (Scheiffele et al.,
2000; Biederer and Scheiffele, 2007). As described previously,
addition of HEK293 cells expressing NL1 to cultured hippocam-
pal neurons induced the clustering of synaptic vesicles at cell–cell
contact sites (Fig. 4A). Cotransfection of NRX14() and to a
lesser extent NRX14() and NRX14() with NL1 inhibited
this synaptogenic activity of NL1 (Fig. 4A,B). As observed for the
neuronal coexpression, this inhibitory function of NRX1 re-
quired the LNS domain, and cotransfection of EphB2 did not
alter NL1 function (Fig. 4B). None of the neurexin isoforms sig-
nificantly altered surface density of NL1 in the transfected
HEK293cells (supplementalFig. S2A, available atwww.jneurosci.
org as supplementalmaterial). This suggests that the inhibition of
NL1 function by postsynaptic neurexins does not require other
neuron-specific components of the postsynaptic apparatus and
depends on the extracellular LNS domain of neurexin.
The simplest model for how postsynaptic neurexins might
inhibit neuroligin activity is by interacting with neuroligins
within the same membrane (in cis-), which might prevent trans-
synaptic interaction with axonal neurexin receptors. To test this
model, we assayed binding of soluble recombinant neurexin to
Figure 2. Epitope-tagged neurexin-1 is detected in axons and dendrites. A, Schematic
representation of GFP-tagged NRX14() used to generate transgenic mice. The EGFP se-
quence was inserted into the extracellular stalk domain of neurexin. The insertion at splice site
4 is marked as 4(), and the LNS domain and transmembrane domain (TMD) are marked. B,
Detection of GFP–NRX14() (anti-GFP, green) in dentate granule cells at P10, triple stained
for calbindin (red) and Hoechst (blue). Scale bar, 100m. C, Detection of GFP–NRX14()-
expressing pyramidal neurons (anti-GFP, green) in the cortex of P10 mouse brains. Nuclei are
stained with Hoechst dye (blue). Scale bar, 100m. D, E, GFP–NRX14() localization was
probed by EM using anti-GFP and SIG as electron-dense labels for EM. D shows an example of
labeling along the plasmamembrane of axons (Ax) in themolecular layer of the dentate gyrus.
Most of the labelingwas in preterminal portions of axons, such as these. E shows an example of
SIG particles clustered along the postsynaptic density (lower of two asterisks) that is postsyn-
aptic to an axon terminal (T) in the molecular layer of the dentate gyrus. Scale bar, 500 nm. No
significant labeling was observed with the anti-GFP antibodies when wild-type tissue was
probed (supplemental Fig. S1B, available at www.jneurosci.org as supplemental material).
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HEK293 cells expressing only NL1 or to
cells that coexpress NL1 and NRX1 iso-
forms. Recombinant NRX14() bound
efficiently to NL1-expressing cells as de-
tected by immunostaining for the Fc tag
on the recombinant protein (Fig. 4C)
(supplemental Fig. S2B, available at
www.jneurosci.org as supplemental mate-
rial). Cotransfection of NRX14() and
NRX14() reduced binding to back-
ground levels, whereas cotransfection of
NRX14() only slightly reduced
NRX14() binding (Fig. 4C). This sug-
gests that cis-expression of NRX1 iso-
forms with NL1 in the same membrane
can prevent NRX1 binding to NL1 in
trans. Because expression of the NRX1
mutant lacking the LNS domain does not
affect neurexin binding (Fig. 4C), this sup-
pression requires the extracellular domain
of neurexin and is likelymediated through
direct cis-interactions with NL1.
We next tested whether cis-expressed
neurexins can also alter the neurexin-
binding capability of endogenous neuroli-
gins in cultured hippocampal neurons.
Compared with EGFP-expressing control
cells, NRX14()-expressing neurons
showed reduced binding of recombinant
NRX14()–Fc protein (Fig. 5A). In con-
trast, expression of NRXLNS did not
change NRX14()–Fc binding. Because
the expression of endogenous neuroligins
in hippocampal neurons might be altered
by neurexin overexpression, we probed
NRX1-expressing cells with a pan-
neuroligin antibody (Fig. 5B,C) (for char-
acterization of the antibody reagent, see
supplemental Fig. S3A,B, available at
www.jneurosci.org as supplemental
material). Surprisingly, NRX14()-
expressing hippocampal neurons showed
a fourfold upregulation of neuroligin im-
munoreactivity outlining the neuronal
processes. Similar neuroligin upregula-
tion was observed for the NRX14()
isoform but not for cells expressing
NRX14() or the NRXLNS mutant
(Fig. 5B). Despite the dramatic increase in
neuroligin level in the -neurexin-
expressing cells, NRX14()–Fc binding
was reduced (Fig. 5A), suggesting that the
neuroligin protein is not available for in-
teraction with neurexin in trans. These
findings confirm the inactivation of neuroligin function by cis-
expressed neurexins and reveal an unexpected coupling between
the expression of neuroligin and neurexin proteins.
The overexpressed neurexin proteins were detected in axons
and dendrites. In dendrites, we observed some diffuse labeling
along the plasma membrane but also punctate structures. Label-
ing with antibodies to EEA1, an early endosomalmarker (Wilson
et al., 2000), and PSD95, a component of the postsynaptic scaf-
fold, revealed that subsets of HA–NRX14() puncta colocal-
ized with EEA1 and PSD95, respectively (Fig. 6A1,A2). Colocal-
ization with these markers was also observed when single
confocal sections were examined at high magnification (supple-
mental Fig. S4, for characterization of the antibody reagent), and
similar results were obtained with expression of HA-tagged
NRX14() and NRX14() (data not shown). Interestingly,
in non-permeabilized, cells a more significant accumulation in
spine heads was observed for NRX14() than for the
-neurexin isoforms (Fig. 6B1). This would be expected if high
Table 1. Subcellular distribution of GFP–NRX14() in cortex and hippocampus of transgenic mice
% SIG particles
Axonal Dendritic Axodendritic
Tissue Intracellular Membranous Intracellular Membranous Contacts
P14 cortex 11 2 51 4 19 3 11 2 8 2
P14 hippocampal formation 6 2 55 6 10 3 17 3 12 3
Sections containing the cerebral cortex and hippocampal formation were subjected to EM analysis after immunolabeling for GFP, the extracellular tag of
transgenically expressed NRX14(), using SIG as the label. SIG particles were identified as residing in dendrites versus axons and at the plasmamembrane
or intracellularly. A significant pool of SIG particles resided exactly at the point of contact between a dendrite and an axon (classified as contacts). For the
cortical tissue, the number of SIG particles encounteredwas 501, all ofwhichwere identifiedwithin 11micrographs sampled randomly from the infragranular
layers. For the hippocampus, 156 SIG particles were encountered from 12 micrographs, taken from the molecular layer of the dentate gyrus. In cortex, all
subcellular domains were identifiable. However, in the hippocampus, 19% of the SIG particles resided within subcellular profiles that were unidentifiable as
a result of immaturity. The values shown represent percentages SEM in each subcellular domain. ANOVA revealed statistically significant differences in the
groupmeans (p 0.00001), indicating highly specific and heterogeneous distribution of NRX14() expression across the subcellular domains. Student’s
t test revealed that this heterogeneity reflects significant enrichment of NRX14() in axonalmembranes (p 0.00001). Specificity of labeling in dendritic
membrane and the axodendritic junctional cleft were revealed by comparing SIG particle distribution between tissue of transgenic and wild-type mice
(Student’s t test, p 0.005).
Figure 3. cis-expression of neurexins reduces synaptogenic activity of neuroligin-1 in hippocampal neurons. A, Hippocampal
neuronswere cotransfectedwith VSV-epitope-taggedNL1 anddifferent HA-epitope-taggedNRX1 expression constructs at 10DIV
and were analyzed 2 d later. For these experiments, the NL1 splice variant containing A and B splice insertions was used because
this is themost abundant variant endogenously expressed in hippocampal neurons. Examples of transfected cells for the following
conditions are shown: NL1 alone, NL1 plus NRX14(),NL1 plus NRX14(), NL1 plus NRX14(), and NL1 plus NRXLNS.
Left column, Immunostaining for the VSV epitope in NL1; middle column, immunostaining for the HA epitope in the NRXs; right
column, immunostaining for the synaptic vesicle marker VAMP2/synaptobrevin. The staining for NL and NRX isoforms was per-
formed in nonpermeabilized cells, and images for all conditions were recorded with identical confocal acquisition settings. Scale
bar, 50m.B, Quantification of VAMP2 immunoreactivity on the transfected cells, normalized to control cells overexpressing only
NL1. Similar results were obtained in at least three independent experimentswith at least 10 cellsmeasured per condition in each
experiment. Data from one experiment are shown (number of cells per condition, n 10; **p 0.01, ***p 0.001). C,
Quantification of average NL1 cell surface staining intensity in dendrites of neurons expressing NL1 alone or together with
neurexin isoforms (n 10 cells; **p 0.01).
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levels of -neurexins led to inactivation of endogenous neuroli-
gins and destabilization of synaptic contacts. To directly test this
possibility, we monitored the density of glutamatergic presynap-
tic vesicle clusters by immunostaining with antibodies to vGlut1
on the transfected cells (Fig. 6B2). Quantitative analysis revealed
a 35–50% reduction in the density of vGlut1 clusters on NRX1-
expressing cells (Fig. 6B2,D), despite the fourfold increase in
neuroligin expression levels (as shown in Fig. 5). In contrast,
expression of NRX14() and the NRXLNS mutant protein
did not have a significant effect on the density of vGlut1puncta
( p  0.05) (Fig. 6B2,D). These findings further support the
model that postsynaptic -neurexin proteins can silence the ac-
tivity of neuroligins and compete for trans-synaptic interactions.
Discussion
Neurexins are a highly polymorphic family of neuronal cell sur-
face receptors that are critical for synaptic function (Ushkaryov et
al., 1992; Missler et al., 2003). However, the subcellular distribu-
tion of neurexin isoforms is unknown. In this study, we directly
demonstrate that neurexins are localized to presynaptic release
sites and postsynaptic densities. A series of cellular neurexin-
binding and synapse assembly assays demonstrate that cis-
expressed -neurexins prevent trans-binding of -neurexins to
NL1, resulting in silencing of the synaptogenic activity of NL1.
This provides a novel molecular mechanism for negative regula-
tion of a synaptic adhesion molecule.
Previous work implicated neurexins primarily in presynaptic
functions. The neurexin protein family was first identified as ax-
onal receptors for -latrotoxin, the black
widow spider toxin that induces massive
synaptic vesicle fusion in the presynaptic
terminal (Ushkaryov et al., 1992; Sugita et
al., 1999). Subsequent studies showed that
clustering of endogenous neurexin or
epitope-tagged NRX1 in axons is suffi-
cient for triggering presynaptic assembly
(Dean et al., 2003). Finally, triple knock-
out mice lacking all -neurexins show de-
fects in the functional coupling of presyn-
aptic calcium channels to the synaptic
release machinery (Missler et al., 2003).
Our findings confirm localization of neur-
exins to presynaptic terminals and active
zones but also uncovered an unexpected
presence in the postsynaptic compartment.
The pan-neurexin antibodies used for
our ultrastructural studies recognized all
neurexin isoforms. Therefore, it still re-
mains to be shown whether there is a mo-
lecularly distinct subset of neurexin iso-
forms that is predominantly enriched in
dendrites or whether many neurexin iso-
forms are represented in both the presyn-
aptic and postsynaptic compartments.
Our finding that GFP–NRX14() was
abundant in dendritic endosomes and at
the dendritic plasma membrane in vivo
suggests that this isoform might be tar-
geted at a significant level to dendrites.
However, at this point, we cannot exclude
that this is a result of mis-sorting under
the overexpression conditions, and addi-
tional studies are required to probe
whether there are neurexin isoforms that
are exclusively sorted to axons or dendrites, respectively. It
should be noted that, in contrast to neurexins, NL1 is strictly
sorted to the somatodendritic domain by a cytoplasmic sorting
signal and is excluded from axons (Dresbach et al., 2004; Iida et
al., 2004; Rosales et al., 2005). This polarity of neuroligins im-
poses directionality on the synaptogenic activity of the hetero-
philic neuroligin–neurexin complex, even if neurexins are not
exclusively localized to axons as previously assumed.
Our cell culture assays indicated that overexpression of
NRX1 in dendrites reduces the density of presynaptic structures
in cultured neurons, a phenotype that is similar to that observed
after suppression of NL1 expression by RNA interference,
dominant-negative mutants, or blocking of neuroligin function
with recombinant neurexin–Fc proteins (Scheiffele et al., 2000;
Graf et al., 2004; Prange et al., 2004; Chih et al., 2005, 2006;
Levinson et al., 2005; Nam and Chen, 2005). Our mixed culture
and neurexin binding assays suggest that cis-expressed neurexins
inactivate NL1 by preventing the interaction with axonal neurex-
ins in trans (see model in Fig. 6C). It should be noted that not all
neurexin isoforms tested in our assays had a potent silencing
activity, and most likely, some neurexin isoforms will have addi-
tional functions in the postsynaptic compartment that are unre-
lated to the silencing of neuroligins (Kattenstroth et al., 2004).
From a structural perspective, it is interesting that the require-
ments for the cis-silencing activity differ frombinding in the trans
configuration. In our assays, we observed similar cis-silencing of
NL1 by NRX14() and NRX14() splice isoforms. In con-
Figure 4. cis-expressed neurexins directly block synaptogenic activity of neuroligin-1. A, HEK293 cells cotransfected with NL1
and different NRX cDNAs were added to hippocampal neurons at 10 DIV, and cocultures were maintained for 2 d. The following
DNAswere transfected:NL1alone (mock),NL1plusNRX14(), NL1plusNRX14(), andNL1plusNRX14(). Cultureswere
immunostained for the VSV epitope onNL1 (left), the HA epitope onNRXs (middle), and VAMP2 to detect synaptic vesicles (right).
Scale bar, 10m. B, Quantification of the VAMP2 accumulation under the HEK293 cells, expressed as percentage of the signal
obtained with cells expressing only NL1. Similar results were obtained in at least three independent experiments for at least 10
cells per condition in each experiment. Data from one experiment are shown (n 10; *p 0.05, ***p 0.001). The NL1 cell
surface expression levels weremeasured by quantification of anti-VSV staining intensity on the transfected HEK293 cells (see Fig.
S2A, available at www.jneurosci.org as supplemental material) (n 10; p 0.05). C, Neurexin binding was quantified as the
average NRX14()–Fc staining intensity in the transfected HEK293 cells. Similar results were obtained in at least three inde-
pendent experiments for at least 10 cells per condition in each experiment. Data from one experiment are shown (n 10; *p
0.05, **p 0.01, ***p 0.001). Images of the cell-binding experiments are shown in supplemental Figure S2B (available at
www.jneurosci.org as supplemental material).
Taniguchi et al. • Silencing of Neuroligin Function J. Neurosci., March 14, 2007 • 27(11):2815–2824 • 2821
Figure 5. -Neurexin overexpression results in upregulation of neuroligins in cis. A, Quantification of NRX14()–Fc binding to control cells (EGFP), cells expressing NRX14(), and cells
expressing NRXLNS (binding is expressed as percentage of binding observed in control cells transfected with EGFP alone; n 20 cells; **p 0.01). B, Quantification of average pan-NL staining
intensity on neurexin-expressing cells and control cells (“None”) (n 10; ***p 0.001). C, Hippocampal neuronswere transfectedwith EGFP or different neurexin isoforms at 12 DIV and analyzed
2 d later. Cellswere coimmunostainedwith antibodies to theHA epitope on the transfected neurexins (top row) andwith anti-pan-NL antibodies (bottom row). Images of the following transfection
conditions are shown: NRX14(), NRX14(), and NRXLNS. Note that the pan-NL antibody does detect endogenous neuroligin staining but that this staining is barely visible in these images.
Because of the strong increase in endogenous neuroligin staining on the neurexin-expressing cells, confocal settings had to be set such that pan-NL staining in the nontransfected cells is very dim.
For an image of endogenous NL staining in control cells, see Figure S3 (available at www.jneurosci.org as supplemental material). Scale bar, 20m.
Figure 6. Dendritic neurexin expression reduces vGlut1 clustering and neurexin binding in dissociated hippocampal neurons. A1, A2, Dissociated hippocampal neurons were cotransfectedwith
expression constructs for EGFP and HA–NRX14() at 14–15 DIV and analyzed by immunohistochemistry at 17 DIV. Cells were triple immunostained with anti-GFP (green), anti-HA (red), and
anti-EEA1 antibodies (A1, blue) or anti-PSD95 antibodies (A2, blue). Some punctate structures that are colabeled for the tagged neurexin and EEA1 or PSD95 are marked by arrows. Images shown
are projected confocal image stacks, but colocalizationwas also observedwhen single optical sectionswere examined at highmagnification (data not shown). Scale bar, 5m.B1,B2, Hippocampal
neurons at 12 DIV were cotransfected with EGFP and with the different NRX isoforms and analyzed 2 d later. Before permeabilization, fixed cells were stained with anti-HA antibodies to detect cell
surface distributions of HA-tagged NRX isoforms NRX14(), NRX14(), and NRX14() (shown in B1). Subsequently, cells were permeabilized and glutamatergic presynaptic sites were
labeled with antibodies to vGlut1 (red), and transfected cells were visualized by EGFP (green) that had been cotransfected with the NRX isoforms (shown in B2). Scale bar, 5m. C, Hypothetical
model for postsynaptic-neurexin function. Postsynaptic NL1 interacts trans-synaptically with NRX1. A pool of postsynaptic NL1 associateswith NRX1 in the postsynapticmembrane in cis and
therefore is not available for trans-synaptic binding. In dendrites, additional NRX1molecules are present in early endosomal structures (EEA1-positive) fromwhere they may recycle over the cell
surface. D, Quantification of vGlut1 cluster density on transfected cells (expressed as percentage of control cells transfected with EGFP alone; n 10; *p 0.05, **p 0.01).
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trast, presence of the 4() insertion strongly reduces trans-
binding affinity of NRX1 for the major endogenous NL1 splice
isoform and abolishes heterophilic adhesion with NL1-
expressing cells (Dean et al., 2003; Boucard et al., 2005; Chih et
al., 2006). Compared with either -neurexin isoform,
NRX14() showed a reduced silencing activity that is consis-
tent with the lack of high-affinity interaction between recombi-
nant -neurexins and NL1AB (Boucard et al., 2005). Although
additional work will be required to explain these differences, we
consider it most likely that neuroligin–neurexin interactions in
cis are mediated through an extracellular binding site that over-
laps with the trans-interaction site but that is not structurally
identical.
Recent studies on the EphA3–ephrinA5 complex have impli-
cated cis-interactions in silencing signaling through this recep-
tor–ligand complex during axon guidance (Yin et al., 2004; Car-
valho et al., 2006). EphA3 and ephrinA5 physically associate with
each other in a cis-manner. This interaction abolishes phosphor-
ylation of EphA3 and the repulsive response of retinal axons to
ephrinAs in trans. This suggests an interesting similarity in silenc-
ing the activity of an axon guidance receptor and a synaptic ad-
hesion protein.
A surprising findingwas the upregulation of endogenous neu-
roligin expression in cultured hippocampal neurons with in-
creased -neurexin levels (Fig. 5). Despite this upregulation, we
observed a decrease in neurexin trans-binding to these cells, in-
dicating that the cis-interactions were sufficient to silence the
additional neuroligin protein. We tested whether neuroligin up-
regulation might represent a compensatory response to changes
in neuronal activity in the neurexin-expressing cells. However,
neuroligin upregulation was unchanged when sodium channel-
dependent action potentials were blockedwith tetrodotoxin (Fig.
S3C). Therefore, it is unlikely that homeostatic scaling mecha-
nisms are responsible for neuroligin upregulation under these
conditions. Regardless of the mechanism, our finding provides
additional evidence for cis-coupling between neuroligin and
neurexin functions in the dendritic compartment.
Silencing of neuroligin by postsynaptic neurexins might be
used in several ways to regulate neuronal function. Postsynaptic
neurexins may restrict the number or size of active neuroligin
domains in the dendritic surface and thereby regulate synapse
formation. A recent study indicated that nonsynaptic complexes
of postsynaptic proteins including NL1might be hotspots for the
initiation of synapse formation (Gerrow et al., 2006). Axonal
interactions with theseNL1 punctamight be suppressed orweak-
ened by interaction with postsynaptic neurexins in cis. Another
possibility is that postsynaptic neurexins may dynamically mod-
ify the activity of neuroligin molecules in existing synapses. In
such amodel, neurexins could be delivered to individual synapses
from dendritic endosomes in response to synaptic signaling. This
could result in selective reduction of synapse size or function and
ultimately provide a mechanism for synapse disassembly. Alter-
natively, postsynaptic neurexins could trigger a transient weak-
ening of synaptic adhesion complexes that may enable structural
remodeling during the maturation of synapses.
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